ABL, Inc.

Clients who want actual immunologists— “We don’t just run samples, we provide you custom method development for your unique, hard-to-measure endpoints.”—partner with us.

We provide the right data. The right data helps our clients define the right clinical candidate, expediting their journey to clinic.

ABL’s scientific immunologists transform your samples into accurate and actionable data, allowing you to make informed decisions at each phase of development.

Learn more: https://ablinc.com/contract-research-organization/

iCELLis 500 adds to ABL's broad adherent cell growth portfolio; it significantly increases volumetric productivity verses classical methods, meets capacity requirements and provides predictable scalability.

Learn more: https://ablinc.com/new-capabilities/

We provide our customers with fully integrated biomanufacturing solution including: cell line and process development, viral vector GMP manufacturing, live virus aseptic fill & finish, QC release testing and regulatory support.

Learn more: https://ablinc.com/biomanufacturing-services/

Don’t worry, we got this. ABL’s 30+ years of commercial GMP experience and 60 years supporting government contracts afford us with technical capabilities and competencies needed to provide clients with .

Learn more: http://ablinc.com/

ABL utilizes assays ADCC and ADCP to test whether vaccines and immunotherapies produce appropriate mechanisms of action for patients, as we are adamant about knowing the ins-and-outs of a product’s functionality to ensure regulatory approval.

Committed to supporting your technical innovations with extensive
immunological assay development and testing experience

Learn more: https://ablinc.com/immunoassay-testing/

Check out how our CEO believe ABL is a catalyst for our clients life-changing innovations.

Visit us at:
https://ablinc.com

Your product success starts here! We're a global expert in viral vector and fill/finish services with 30+ years of viral-vector development and GMP production to accelerate your novel gene therapies, vaccines, oncolytics and immunotherapies. Learn more: https://ablinc.com/aseptic-fill-finish/

ABL's biomarker analysis is the dependable, quality service to accurately serve as your early diagnostic tool for the efficacy of therapeutic interventions.

ABL has the right immunology specialists to get the job done!

Learn more:
https://ablinc.com/biomarker-cytokine-detection/

Teams of highly skilled well trained scientists are embedded in every ABL manufacturing facility, each specializing in a critical area of bioprocessing. Learn more: https://ablinc.com/process-development/…

We do not do the same thing twice.
As a CDMO that specializes in Gene Therapy, Oncolytics and Viral Vector Vaccines we have deep scientific understanding of viral products.

With decades of established viral vectors expertise; each viral vector GMP manufacturing project is customized to our client’s novel therapy.

Learn more: https://ablinc.com/biomanufacturing-services/

There’s a shared passion for the science and commitment to the patient. With over 50 client IND submissions under our belt, we understand the complexity of taking a drug from concept to clinic. ABL, viral vector CDMO specialist and your catalyst for life changing innovations.

Contact us:
https://ablinc.com/about-abl/contact-us/

We’re Hiring ! ABL is actively seeking a Lab Research Specialist- Immunology for immediate hire. Join a team that has a reputation for our technical prowess and scientific agility. Let’s take on life’s challenging diseases through life-changing vaccines and biotherapeutics, together!

BS/MS in life science required.

Learn more and apply here: https://xtalks.com/job/lab-research-specialist-immun-2/

As experts in lentivirus biomanufacturing, ABL can increase the speed to market of your viral vector innovation. Get the white paper to see how.

https://ablinc.com/lentivirus/

Our process development (PD) platforms emulate our GMP platforms allowing us to scale up with ease after optimization studies.

Learn more:
https://ablinc.com/process-development/

ABL is uniquely positioned to perform standalone live virus fill finish services using a Watson Marlow Flexicon FPC 50W Single Beam Filler. Filler is stored in a Grade A RABS located in a Grade B Room.

We have active and passive viable monitoring, continuous non-viable particulate monitoring, and personnel monitoring—all employed during filling operations.

And operators are required to pass gowning qualification and qualify through semi-annual media fill simulations.

Learn more: https://ablinc.com/aseptic-fill-finish/

Our technical agility and ability bring immediate clarity to ambiguity.

Discover how ABL can bring clarity to your organization: https://ablinc.com

ABL has worked with unique processes, cell types and testing platforms partnering with the flexibility and experience to sufficiently handle your needs, so it’s more of a partnership.

Learn more:
https://ablinc.com

The iCELLis 500+ significantly increases volumetric productivity verses classical adherent methods. iCELLis nano and iCELLis 500+ in PD and in our GMP suites provide predictable scalability from R&D to manufacturing.

Learn more: http://ow.ly/zRQi50EDHp9

Learn more: https://ablinc.com/biomanufacturing-services/

Our deep understanding of viral vector manufacturing includes: adenovirus, AAV, influenza, HSV, MVA, vaccinia, HIV, lentivirus, maraba and oncolytic viruses, VSV, VLPs, lytic/non-lytic viruses, enveloped/non-enveloped viruses and more.

Learn more http://ow.ly/QLe750AxfhK

Today we say goodbye and huge THANK YOU to our incredible ABL 2021 Summer Interns! We are so grateful for everything they have managed to accomplish, their enthusiasm and wonderful attitudes that inspired us and pushed us forward! We are excited to see what they accomplish next.

Aiza Viryam | George Mason University

James DeVol | Auburn University

Allison Marcus | The George Washington University

Lauryn Mitchell | Mount St. Mary's University

Grace Reachmack | Towson University

We understand the race to clinic depends on timely data. We ensure data in hand within days of project initiation, to galvanize critical, real-time decisions on product advancement.
We work to align with market dynamics and speed-to-market demands.
Learn more: https://ablinc.com/contract-research-organization/

Learn more: https://ablinc.com/qc-testing/

Our Mission:
ABL harnesses decades of pioneering science and manufacturing expertise to drive the development of innovative therapies and vaccines supporting the biopharmaceutical industry in their quest to improve public health.

Learn more: https://ablinc.com/about-abl/overview/

Our team at ABL consults on many indications including: oncology, immuno-oncology, infectious diseases, neurological diseases, genetic disorders and autoimmune diseases.

Get your consultation today: https://ablinc.com/

Streamline your project with a CDMO partner having everything you need--product design, process development, in-house manufacturing, QC testing and fill/finish--all under one roof decreasing variability and providing a catalyst for your vaccine or therapeutic to get regulatory approval and progress from bench to clinic to market.

We are the difference-maker; strategic viral vector GMP biomanufacturer and contract research organization and the catalysts for bringing your life-changing innovations to market—partnering with you to save lives.

Visit us:
https://ablinc.com/